Virginia Zabaleta

501 total citations
8 papers, 423 citations indexed

About

Virginia Zabaleta is a scholar working on Pharmaceutical Science, Oncology and Biomaterials. According to data from OpenAlex, Virginia Zabaleta has authored 8 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmaceutical Science, 3 papers in Oncology and 3 papers in Biomaterials. Recurrent topics in Virginia Zabaleta's work include Nanoparticle-Based Drug Delivery (3 papers), Cancer Treatment and Pharmacology (3 papers) and Advanced Drug Delivery Systems (3 papers). Virginia Zabaleta is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Cancer Treatment and Pharmacology (3 papers) and Advanced Drug Delivery Systems (3 papers). Virginia Zabaleta collaborates with scholars based in Spain, France and Romania. Virginia Zabaleta's co-authors include Juan M. Irache, Maite Agüeros, Socorro Espuelas, M. A. Campanero, Hesham Salman, Miguel Ángel Campanero, Nekane Martín‐Arbella, Gemma Quincoces, Iván Peñuelas and Gilles Ponchel and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Virginia Zabaleta

8 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Zabaleta Spain 7 267 216 102 53 45 8 423
Garima Joshi India 13 256 1.0× 160 0.7× 124 1.2× 36 0.7× 50 1.1× 30 505
Rahul Vats India 10 237 0.9× 86 0.4× 124 1.2× 34 0.6× 32 0.7× 20 468
Anil Kumar Babbar India 12 241 0.9× 139 0.6× 131 1.3× 27 0.5× 65 1.4× 14 498
Ankitkumar S. Jain India 10 202 0.8× 136 0.6× 139 1.4× 23 0.4× 57 1.3× 12 429
Jagruti Desai India 12 226 0.8× 87 0.4× 113 1.1× 34 0.6× 33 0.7× 24 402
Mark D. Coffin United States 6 219 0.8× 108 0.5× 78 0.8× 105 2.0× 35 0.8× 9 423
Bashar Al-Taani Jordan 14 242 0.9× 109 0.5× 73 0.7× 27 0.5× 56 1.2× 34 470
Saurabh Wadhwa United States 12 187 0.7× 91 0.4× 75 0.7× 42 0.8× 58 1.3× 14 414
Dong‐Wuk Kim South Korea 12 336 1.3× 133 0.6× 94 0.9× 50 0.9× 35 0.8× 13 547
Robhash Kusam Subedi South Korea 7 391 1.5× 183 0.8× 205 2.0× 37 0.7× 84 1.9× 10 664

Countries citing papers authored by Virginia Zabaleta

Since Specialization
Citations

This map shows the geographic impact of Virginia Zabaleta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Zabaleta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Zabaleta more than expected).

Fields of papers citing papers by Virginia Zabaleta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Zabaleta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Zabaleta. The network helps show where Virginia Zabaleta may publish in the future.

Co-authorship network of co-authors of Virginia Zabaleta

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Zabaleta. A scholar is included among the top collaborators of Virginia Zabaleta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Zabaleta. Virginia Zabaleta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Martín‐Arbella, Nekane, et al.. (2014). In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration. European Journal of Pharmaceutics and Biopharmaceutics. 97(Pt A). 280–289. 99 indexed citations
2.
Zabaleta, Virginia, Pilar Calleja, Socorro Espuelas, et al.. (2013). Nanoparticules mucopénétrantes : véhicules pour l’administration orale du paclitaxel. Annales Pharmaceutiques Françaises. 71(2). 109–118. 6 indexed citations
3.
Román, Beatriz San, Victoria Garrido, Pilar M. Muñoz, et al.. (2012). The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice. Veterinary Research. 43(1). 31–31. 4 indexed citations
4.
Zabaleta, Virginia, Gilles Ponchel, Hesham Salman, et al.. (2012). Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. European Journal of Pharmaceutics and Biopharmaceutics. 81(3). 514–523. 98 indexed citations
5.
Agüeros, Maite, Virginia Zabaleta, Socorro Espuelas, M. A. Campanero, & Juan M. Irache. (2010). Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. Journal of Controlled Release. 145(1). 2–8. 128 indexed citations
6.
Porfire, Alina, Virginia Zabaleta, Carlos Gamazo, Sorin E. Leucuţa, & Juan M. Irache. (2009). Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. International Journal of Pharmaceutics. 390(1). 37–44. 28 indexed citations
7.
Salman, Hesham, et al.. (2008). Micro-organism-like nanoparticles for oral antigen delivery. Journal of Drug Delivery Science and Technology. 18(1). 31–39. 8 indexed citations
8.
Zabaleta, Virginia, Miguel Ángel Campanero, & Juan M. Irache. (2007). An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles. Journal of Pharmaceutical and Biomedical Analysis. 44(5). 1072–1078. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Garima Joshi Breakdown of academic impact, for papers by Rahul Vats Breakdown of academic impact, for papers by Anil Kumar Babbar Breakdown of academic impact, for papers by Ankitkumar S. Jain Breakdown of academic impact, for papers by Jagruti Desai Breakdown of academic impact, for papers by Mark D. Coffin Breakdown of academic impact, for papers by Bashar Al-Taani Breakdown of academic impact, for papers by Saurabh Wadhwa Breakdown of academic impact, for papers by Dong‐Wuk Kim Breakdown of academic impact, for papers by Robhash Kusam Subedi
Rankless by CCL
2026